ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Ann Thorac Surg 2008;85:113-119. doi:10.1016/j.athoracsur.2007.08.025
© 2008 The Society of Thoracic Surgeons

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Alfredo Trento
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goland, S.
Right arrow Articles by Siegel, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goland, S.
Right arrow Articles by Siegel, R. J.
Related Collections
Right arrow Coronary disease
Right arrow Valve disease
Right arrowRelated Article


Original Articles: Cardiovascular

Thoracic Aortic Arteriosclerosis in Patients With Degenerative Aortic Stenosis With and Without Coexisting Coronary Artery Disease

Sorel Goland, MDc, Alfredo Trento, MDb, Lawrence S.C. Czer, MDa, Shervin Eshaghian, MDa, Kirsten Tolstrup, MDa, Tasneem Z. Naqvi, MDa, Michele A. De Robertis, RNb, James Mirocha, MSb, Kiyoshi Iida, MDa, Robert J. Siegel, MDa,*

a Division of Cardiology, Cedars-Sinai Medical Center, Los Angeles, California
b Department of Cardiothoracic Surgery, Cedars-Sinai Medical Center, Los Angeles, California
c Department of Cardiology, Kaplan Medical Center, Israel

Accepted for publication August 13, 2007.

* Address correspondence to Dr Siegel, Division of Cardiology, Room 5623, Cedars-Sinai Medical Center, 8700 Beverly Blvd, Los Angeles, CA 90048 (Email: siegel{at}cshs.org).


    Abstract
 Top
 Abstract
 Introduction
 Patients and Methods
 Results
 Comment
 References
 
Background: The association between the severity of arteriosclerosis in the thoracic aorta in patients with isolated aortic stenosis (AS) and with concomitant coronary artery disease (CAD) has been not evaluated. Therefore, the aim of our study was to compare the thoracic aortic atheroma extent and severity in patients with severe AS alone and with concomitant CAD by intraoperative transesophageal echocardiography.

Methods: We retrospectively evaluated echocardiograms of 105 consecutive patients with severe degenerative AS who underwent aortic valve replacement. Sixty patients had concomitant CAD (AS/CAD) on coronary angiography and 45 had no CAD (AS alone). These patients were compared with 54 sex- and age-matched patients without AS or CAD. Aortic atheroma (localized intimal thickening of >3 mm) prevalence and morphology in three segments of aorta were assessed with echocardiography.

Results: There were 62 men, mean age 75.3 ± 9.4 years. No difference was observed in age, sex, and risk factors for arteriosclerosis other than hypercholesterolemia among AS/CAD, AS alone, and control groups (88%, 67%, 41%, respectively; p < 0.0001). The AS/CAD group had a significantly higher rate of aortic root calcification (68%, 36%, 26%, respectively; p < 0.0001) and aortic atheroma (ascending aorta [26%, 20%, 14%, respectively; p = 0.03]; aortic arch [78%, 36%, 30%, respectively; p < 0.0001]; descending aorta [72%, 42%, 29%, respectively; p < 0.0001]) than AS alone or control subjects. Patients with AS/CAD also had more complex atheromas in the aortic arch (48%, 20%, 7%, respectively; p < 0.0001). Significant differences in extension of aortic arteriosclerosis (presence of plaques in two or three segments) were observed among the groups (70%, 31%, 18%, respectively; p < 0.0001).

Conclusions: Patients with severe AS and coexisting CAD have more extensive arteriosclerotic changes in the thoracic aorta compared with those with AS alone and control subjects. Preoperative evaluation of the thoracic aorta and more aggressive lipid therapy should be considered in these patients.


    Introduction
 Top
 Abstract
 Introduction
 Patients and Methods
 Results
 Comment
 References
 
Degenerative aortic stenosis (AS) is one of the most common valvular heart diseases, resulting in valve replacement [1, 2]. Recent studies have reported an association between aortic valve calcification and arterial arteriosclerosis, suggesting that the degenerative changes of the aortic valve leading to AS may be part of a similar arteriosclerotic process [3, 4]. Transesophageal echocardiography (TEE) allows accurate assessment of the degree of arteriosclerosis in the thoracic aorta [5–10]. The severity and extent of arteriosclerosis in the thoracic aorta are strong risk factors for ischemic stroke and for overall vascular risk [11–13]. The severity of aortic arteriosclerosis has been shown to correlate with coronary artery disease (CAD). More recent studies have been demonstrated a link between arteriosclerotic changes in ascending aorta and AS. However, they did not look at the subset of patients with AS alone and those with coexisting CAD [14, 15]. It is still not clear whether CAD in patients with degenerative AS is associated with more extensive and severe arteriosclerosis of the thoracic aorta than patients with AS alone or patents without both these conditions. Therefore, we compared the presence and extent of thoracic aortic atheroma by intraoperative TEE in patients with severe degenerative AS with and without coexisting CAD, and matched control subjects having neither AS nor CAD.


    Patients and Methods
 Top
 Abstract
 Introduction
 Patients and Methods
 Results
 Comment
 References
 
We retrospectively evaluated TEEs of 105 consecutive patients with severe degenerative AS (tricuspid aortic valve area <1 cm2) who underwent aortic valve replacement surgery (AVR). This study was approved by the Institutional Review Board at Cedars-Sinai Medical Center with a waiver to obtain consent based on the retrospective study nature and hiding of identification of patient data. All patients are prospectively entered into an Institutional Review Board–certified quality assurance database. Among all patients, 60 had concomitant CAD (AS/CAD) on coronary angiography (>50% coronary artery narrowing), and 45 had no CAD (AS/no CAD). All patients with AS and each group according to presence of CAD were compared with 54 sex-and age-matched patients without AS (on echocardiography) or CAD (on coronary angiography or no evidence of inducible ischemia on nuclear imaging). We defined diabetes mellitus as hyperglycemia requiring pharmacologic therapy; hypertension as either a systolic or diastolic increase in blood pressure (>140/90 mm Hg) or use of antihypertensive therapy; hypercholesterolemia as a total cholesterol level of greater than 200 mg/dL or use of lipid-lowering agents; and cigarette smoking as being an active smoker or having a history of smoking at least 10 pack-years within the last 20 years. An HDI-5000 ultrasound system with a 5-MHz TEE multiplane probe was used (Philips Medical System, Bothell, WA). Images were digitized, and off-line measurements were performed with the VERICIS Echo Review application (Camtronics Medical Systems Inc, Hartland, WI). Transesophageal echocardiography was performed in 105 patients as part of a routine intraoperative TEE before and after AVR. Fifty-five patients who make up the control group were referred for TEE by their cardiologists as a part of the clinical work-up for different reasons such as suspected endocarditis or atrial fibrillation, or evaluation of valvular lesions other than AS. Transesophageal echocardiography images were obtained using transgastric, midesophageal, and basal views. All segments of the thoracic aorta, including both the ascending and descending aorta and the aortic arch, were evaluated for the presence of plaques between angles of 0 and 90 degrees. Plaque thickness was defined as the thickness of the intima and media layers of the walls measured perpendicularly during systole on a frozen frame. Maximum thickness of the plaques in each region was recorded. The aortic intima was evaluated for changes in thickening, protrusion, mobile components, or ulceration. Aortic atheroma was defined as localized intimal thickening of 3 mm or greater. Complex lesions were plaques extending greater than 5 mm, or plaques that were protruding, mobile, or ulcerated. Aortic atheroma score was calculated as the sum of maximum plaque thickness of three segments and was used to assess the severity and extent of aortic arteriosclerosis. Atheroma prevalence and morphology in three segments of the aorta (ascending aorta, aortic arch, and descending aorta) were assessed. All TEEs were reviewed by one echocardiographer without knowledge of CAD status. In addition, 40 randomly selected studies were interpreted independently by the echocardiographer with excellent agreement (98%) about the presence or absence of thoracic aortic atheroma.

Data are presented as mean ± standard deviation. Statistical analysis was performed using a commercially available statistical package (SPSS 12 statistical software; SPSS Inc, Chicago, IL, or SAS version 9.1; SAS Institute, Cary, NC). Comparisons across several different groups were made by analysis of variance for continuous data and {chi}2 tests (with Fisher’s exact test when appropriate) for categorical data. The significant baseline predictor variables were entered into a stepwise multivariable logistic regression model to predict aortic atheroma. A probability value of less than 0.05 was considered statistically significant.


    Results
 Top
 Abstract
 Introduction
 Patients and Methods
 Results
 Comment
 References
 
Clinical Characteristics and Risk Factors
A total of 105 patients with severe AS who underwent AVR (62 men, 59%; mean age, 75.3 ± 9.4 years; aortic valve area, 0.71± 0.24 cm2) and 54 age- and sex-matched patients without AS and CAD constituted this study. Patients with AS had a somewhat higher incidence of diabetes mellitus than those without AS (31% versus 18%; p = 0.08). There was a significant difference in smoking (54% versus 33%; p = 0.008), hyperlipidemia (83% versus 42%; p < 0.0001), and the use of cholesterol-lowering agents (77% versus 35%; p < 0.0001) in patients with AS/CAD compared with AS alone. No difference was found in age, sex, and risk factors for arteriosclerosis other than hyperlipidemia among AS/CAD, AS alone, and control groups (Table 1). A higher incidence of hyperlipidemia was found in patients with AS/CAD (88%, 67%, 41%, respectively; p < 0.0001) than in those with AS alone or the control subjects, and subsequently more patients in the combined group were treated for hyperlipidemia (88%, 62%, 34%, respectively; p < 0.0001).


View this table:
[in this window]
[in a new window]

 
Table 1 Comparison of Baseline Characteristics and Arteriosclerosis Risk Factors Among Three Groups
 
Aortic Plaque Prevalence and Morphology
The prevalence of aortic root calcification (54% versus 26%; p = 0.008) was significant higher in patients with AS compared with control subjects as well as the prevalence of atheroma in the ascending aorta (24% versus 7%; p < 0.0001), arch (60% versus 30%; p < 0.0001), and descending aorta (59% versus 28%; p < 0.0001). Table 2 shows the differences in the prevalence of aortic atheroma in any and in each of the thoracic aorta segments among patients with AS alone, AS/CAD, and control subjects. On TEE, the AS/CAD group had a significantly higher rate of aortic root calcification (68%, 36%, 26%, respectively; p < 0.0001) and aortic atheroma in the ascending aorta (26%, 20%, 14%; p = 0.03), aortic arch (78%, 36%, 30%, respectively; p p < 0.0001), and the descending aorta (72%, 42%, 29%, respectively; p < 0.0001) compared with AS alone or control patients. The comparison among the three groups is presented in Figure 1. Figure 1A shows a significantly higher prevalence of aortic atheroma in the ascending aorta in the AS groups compared with the control group. However, aortic root calcification was found more frequently in AS/CAD compared with both AS/no CAD patients and control subjects (p < 0.001 and p < 0.0001, respectively). Figure 1B demonstrates that there is a significantly higher prevalence of aortic atheroma, both simple and complex, in the aortic arch in patients having AS/CAD compared with AS/no CAD and control subjects. There were no significant differences obtained between control subjects and patients with AS/no CAD. As shown in Figure 1C, the same trend is present for the differences in atheroma prevalence in the descending aorta. The overall prevalence of atheroma and the prevalence of simple atheroma were higher in the AS/CAD patients than in both AS/no CAD and control subjects. The prevalence of complex atheromas in the descending aorta was overall low and significantly lower in control subjects than in patients with AS. Examples of various types of atheroma in the thoracic aorta by intraoperative TEE are shown in Figure 2.


View this table:
[in this window]
[in a new window]

 
Table 2 Prevalence of Aortic Atheroma Among Patients With Degenerative Aortic Stenosis With and Without Coronary Artery Disease and the Control Group
 

Figure 1
View larger version (48K):
[in this window]
[in a new window]

 
Fig 1. (A) Comparison of prevalence of aortic atheroma in any segment of the thoracic aorta, aortic root calcification and ascending aorta among three groups: patients with degenerative aortic stenosis (AS) with and without coronary artery disease (CAD) and the control group. (B) Comparison of aortic atheroma prevalence and morphology in the aortic arch among three groups: patients with degenerative AS with and without CAD and the control group. (C) Comparison of aortic atheroma prevalence and morphology in the descending aorta among three groups: patients with degenerative AS with and without CAD and the control group. (D) Comparison of aortic atheroma score among three groups: patients with AS with and without CAD and the control group. Aortic atheroma score (the sum of maximum plaque thickness of three segments) has been measured in patients having atheroma (83% in AS/CAD group, 62% in AS/no CAD group, and 44% in the control group patients). Probability values are for comparisons among the three groups. (Ao = aorta; Ao root Ca = aortic root calcification; Asc Ao = ascending aorta.)

 

Figure 2
View larger version (84K):
[in this window]
[in a new window]

 
Fig 2. Various types of atheroma in the thoracic aorta evaluated by intraoperative transesophageal echocardiography in patients with severe aortic stenosis and coexisting coronary artery disease. The left top image shows a protruding complex atheroma of the aortic arch (arrow). The left bottom image is an example of a simple atheroma in the junction of aortic arch and descending aorta (arrow). The right top image demonstrates highly mobile sessile atheroma in the aortic arch (arrow), and the right bottom image shows multiple protruding atheromas with very thick aortic wall (arrow).

 
Significant differences in the extent of aortic arteriosclerosis (presence of plaques in two or three segments) was found among the three groups (70%, 31%, 18%, respectively; p < 0.0001). Aortic atheroma score (the sum of maximum plaque thickness of three segments) has been measured in those patients who had atheroma (83.3% in AS/CAD, 62.2% in AS/no CAD groups, and 44.4% in control group). Figure 1D shows significantly higher aortic atheroma scores in patients with combined AS/CAD compared with both with AS/no CAD and control subjects. Finally, in patients with aortic atheromas significantly higher low-density lipoprotein levels (93.0 ± 37.1 versus 73.1 ± 29.5 mg/dL; p = 0.03) were found compared with those without atheroma, with no significant differences in total cholesterol (p = 0.3), triglycerides (p = 0.3), and high-density lipoprotein levels (p = 0.4). When the significant baseline variables were entered into a stepwise multivariable logistic regression model, CAD (odds ratio, 5.09; 95% confidence interval, 1.1 to 7.2; p = 0.02) was found to be the only predictor of the presence of aortic atheroma in patients with severe AS.

Among 105 patients, 5 patients (4.7%) experienced a perioperative stroke, and in 4 of them complex atheromas (3 of them protruding and mobile) in the aortic arch were present on TEE. In all patients, brain computed tomography was obtained that verified cerebral infarction. Three patients experienced unilateral hemiparesis during the first 48 hours after surgery. In 1 patient a focal deficit (hemiplegia and aphasia) occurred immediately after he awoke from anesthesia. One patient experienced acute confusion state early after surgery with evidence of infarction on computed tomography. Among 38 patients who had complex aortic arch atheroma on TEE, the incidence of postoperative stroke was 16%. The operative mortality was 0.9%.


    Comment
 Top
 Abstract
 Introduction
 Patients and Methods
 Results
 Comment
 References
 
This study evaluated the association between coexisting CAD and AS and the severity of atheromatous changes in the aorta. Comparing two groups of patients with AS (with and without CAD) and the age- and sex-matched control group, we were able to determine the impact of each of these conditions on severity and extension of arteriosclerotic changes in the thoracic aorta. Similar to a prior report, we found that patients with severe AS had a higher prevalence of arteriosclerotic changes in all portions of the thoracic aorta compared with the age- and sex- matched control group with neither AS nor CAD [15]. However, using the aortic atheroma scores, patients with AS/CAD had significantly higher rates of aortic atheroma in all segments and more extensive arteriosclerotic changes compared with those with AS/no CAD and control subjects. In addition, patients with combined AS/CAD had significantly higher prevalence of both simple and complex atheromas in the aortic arch, compared with those with AS/no CAD and control subjects. Although no significant difference was found between patients with AS/no CAD and the control group, CAD appears to be strongly associated with thoracic aortic arteriosclerosis. Using a stepwise multivariable logistic regression model, CAD was found to be the only significant predictor of the presence of aortic atheroma in patients with severe AS.

It has been demonstrated that aortic plaques are related to the presence and severity of CAD [16] and of the intimal thickening in the carotid artery [17]. In addition, a recent study found a strong association between the presence of AS and severity of aortic atheromas, suggesting that AS might be a manifestation of the arteriosclerotic process [15]. Although a large number of patients in this study had concomitant coronary artery bypass grafting, this study did not look at patients with isolated AS separately. The difference in aortic arteriosclerosis between patients with degenerative AS and bicuspid AS has been described, suggesting that the pathogenesis of these two diseases might be different [18]. Transesophageal echocardiography is an accurate method to assess arteriosclerotic plaques in the thoracic aorta and is considered to be the current noninvasive clinical "gold standard." Magnetic resonance imaging findings in terms of aortic plaque composition, extent, and size closely correlate with TEE [19].

A high incidence of perioperative stroke (25%) in patients with protruding atheromas has been reported compared with those with less severe aortic arch atheromas (2%) [20]. In that study the intraoperative diagnosis changed the surgical approach in 8%, including changing of the site of cannulation or debridement of atheroma during circulatory arrest. The presence of complex aortic arch atheromas has been shown to increase the stroke rate by sixfold after heart surgery [21]. In our study, 16% of patients with complex aortic arch experienced perioperative stroke. The overall incidence of perioperative stroke in our study is 4.7% and was similar to previously published data [15]. Of note, 4 of 5 of our patients with perioperative stroke had complex aortic arch atheromas. Perioperative stroke has been mostly attributed to manipulations of the ascending aorta during graft anastomosis, cross-clamping, or cannulation with the "sandblasting effect" from the high-flow jet [22]. Therefore, patients with severe aortic arch arteriosclerosis represent a high risk for heart surgery with cannulation of the aortic arch. The detection of complex aortic atheromas and choice of the surgical approach can reduce the incidence of this debilitating complication. Intraoperative palpation of the aorta has been found to be insensitive for detecting and assessing the severity of the lesions [23]. Transesophageal echocardiography has been demonstrated to be much more sensitive than palpation to detect ascending aorta atheromas [20]. During surgery epiaortic ultrasound has also been shown to predict stroke [22]. However, this technique is used only intraoperatively, whereas TEE is a safe and sensitive tool for preoperative assessment of thoracic aortic arteriosclerosis, identifying high-risk patients for stroke and helping in the decision making and planning of different surgical approaches in this patient population. Moreover, it has been shown that TEE-guided cannulation reduces mortality and stroke [24]. Unlike patients with severe arteriosclerosis of the aorta who undergo coronary artery bypass grafting, in whom off-pump techniques can be used without any manipulation of the aorta, in those who require AVR either aortic clamping or hypothermic circulatory arrest is currently needed. In patients with a milder degree of aortic arch arteriosclerosis the uses of a short aortic cannula or a soft-flow cannula have been introduced with no perioperative stroke [25]. Several reports on a small number of patients described different techniques for managing aortic valve disease in patients with severe aortic arch arteriosclerosis including a "no-touch" technique in which an alternative site for arterial cannulation is chosen and AVR is performed under hypothermic circulatory arrest [26, 27]. However, the duration of hypothermic circulatory arrest was long; therefore, an alternative strategy such as aortic endarterectomy in patients with aortic arteriosclerosis has been introduced. This technique, however, has been not shown to prevent embolization [21]. Another method using balloon occlusion of the ascending aorta after performing an aortotomy with the use of hypothermic circulatory arrest for a brief time has been suggested, but demonstrated an increased risk for embolizations [28]. In a recent study of 62 patients with severely arteriosclerotic ascending aortas who underwent AVR, five different strategies were used to manage the ascending aorta [29]. These techniques included AVR with the use of hypothermic circulatory arrest (39%), ascending aortic endarterectomy (26%), ascending aortic replacement (19%), aortic inspection and cross-clamping during hypothermic circulatory arrest (10%), and balloon occlusion of the ascending aorta (6%). The postoperative death was 14%, and 10 % experienced stroke. Although strokes were limited to those with AVR with hypothermic circulatory arrest and aortic endarterectomy, the choice of the operative technique did not influence the risk of stroke. Complete AVR during hypothermic circulatory arrest (the "no-touch" technique) had required a prolonged period of circulatory arrest. In this study authors concluded that ascending aortic replacement is a preferred technique, as it required a short period of hypothermic circulatory arrest and showed comparable mortality with a low risk of stroke.

Degenerative AS has many similarities in the arteriosclerotic plaque histology as well as many of the same predisposing risk factors. Despite the similarities in clinical risk factors such as hypercholesterolemia or hypertension, others such as sex, diabetes, and endothelial dysfunction have not been as strongly linked to AS [30]. Some of the histopathologic findings associated with degenerative aortic valve disease and arteriosclerosis are different. For example, calcific changes, which can be also seen in arteriosclerotic plaques, occur earlier and are more prominent in calcific aortic valve disease [3]. Moreover, in contrast to the gradual progression of degenerative AS, acute plaque rupture can occur in CAD. These discrepancies may help to explain the limited response to statin therapy in altering of aortic valve disease progression compared with well-established efficacy on coronary artery plaque regression and reversal of carotid intimal-medial thickening by statins [31]. At present, based on the available data there are no indications for statin therapy solely on the basis of AS alone if conventional guidelines for statin therapy are not met [32–34]. Despite the fact that both patient populations with AS and with CAD were found to have strong association with aortic arteriosclerosis, it still remains unclear why some patients with severe AS have normal coronary arteries and whether both CAD and AS are linked to aortic atheroma. The present study clearly demonstrates that coexisting CAD in patients with AS appears to have an extremely strong association with advanced thoracic aortic arteriosclerosis, whereas those without CAD had only a trend for higher prevalence of atheroma in the thoracic aorta compared with control subjects.

Clinical Implications
From our findings, several clinical implications can be drawn. The presence of complex aortic arch atheromas on TEE appears be associated with an increased risk of perioperative stroke. A preoperative and intraoperative evaluation of the thoracic aorta should be considered, especially in patients having combined aortic and coronary disease. In selected patients with severe arteriosclerosis of the ascending aorta and aortic arch, coronary artery bypass grafting can be done without cardiopulmonary bypass, and alternative surgical approaches including ascending aortic replacement or "no-touch" procedures without aortic clamping must be considered. Recently developed transapical surgical approach of implantation of a catheter-mounted valve combined with off-pump coronary artery bypass grafting is being pursued to reduce the risk of stroke in this high-risk population. Finally, it is not surprising that in patients with AS having thoracic aorta atheromas, significant higher low-density lipoprotein levels were found compared with those who had no arteriosclerotic changes. However, even in patients with atheroma the mean low-density lipoprotein level was less than 100 mg/dL, suggesting the need for more aggressive treatment in this population.

Conclusions
Among patients with severe AS, coexisting CAD is strongly associated with the presence and severity of arteriosclerotic changes in the thoracic aorta. Careful presurgical evaluation and alternative approaches in patients with combined AS and CAD, who represent a high-risk population in terms of severe arteriosclerosis and calcification of the ascending aorta, should be considered.


    References
 Top
 Abstract
 Introduction
 Patients and Methods
 Results
 Comment
 References
 

  1. Selzer A. Changing aspects of the natural history of valvular aortic stenosis N Engl J Med 1987;317:91-98.[Medline]
  2. Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve diseaseCardiovascular Health Study. J Am Coll Cardiol 1997;29:630-634.[Medline]
  3. Otto CM, Kuusisto J, Reinchenbach DD, Gown AM, O’Brien KD. Characterization of the early lesion of "degenerative" valvular aortic stenosis: histologic and immunohistochemical studies Circulation 1994;90:844-853.[Abstract/Free Full Text]
  4. Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic valve sclerosis with cardiovascular mortality and morbidity in the elderly N Engl J Med 1999;341:142-147.[Medline]
  5. Tribouilly C, Peltier M, Colas L, Senni M, Ganry O, Lesbre JP. Fibrinogen is an independent marker for thoracic aortic atherosclerosis Am J Cardiol 1998;81:321-326.[Medline]
  6. Dressler FA, Craig WR, Castello R, Labovitz AJ. Mobile aortic atheroma and systemic emboli: efficacy of anticoagulation and influence of plaque morphology on recurrent stroke J Am Coll Cardiol 1998;31:134-138.[Medline]
  7. Nihoyannopoulos P, Joshi J, Athansopoulog G, Oakley CM. Detection of atherosclerotic lesions in the aorta by transesophageal echocardiography Am J Cardiol 1993;71:1208-1212.[Medline]
  8. Pohle K, Popers D, Moshage W, Stilianakis N, Daniel WG, Achenbach S. Progression of aortic calcification: association with coronary atherosclerosis and cardiovascular risk factors Circulation 2001;104:1927-1932.[Abstract/Free Full Text]
  9. Witteman JCM, Kannel WB, Wolf PA, et al. Aortic calcified plaques and cardiovascular disease (The Framingham Study) Am J Cardiol 1990;66:1060-1064.[Medline]
  10. Agmon Y, Khandheria BK, Meissner I, et al. Aortic valve sclerosis and aortic atherosclerosis: different manifestations of the same disease? J Am Coll Cardiol 2001;38:827-834.[Medline]
  11. Tunick PA, Rozenzweig BP, Katz ES, Freedberg RS, Perez JL, Kronzon I. High risk for vascular events in patients with protruding aortic atheromas: a prospective study J Am Coll Cardiol 1994;23:1085-1090.[Medline]
  12. Mitusch R, Doherty C, Wucherpfenning H, et al. Vascular events during follow-up in patients with aortic arch atherosclerosis Stroke 1997;28:36-39.[Abstract/Free Full Text]
  13. Cohen A, Tzourio C, Bertrand B, Chauvel C, Bousser MG, Amarenco P. Aortic plaque morphology and vascular events: a follow-up study in patients with ischemic strokeFAPS Investigators. French Study of Aortic Plaques in Stroke. Circulation 1997;96:3838-3841.[Abstract/Free Full Text]
  14. Taniguchi H, Momiyama Y, Fayad ZA, et al. In vivo magnetic resonance evaluation of associations between aortic atherosclerosis and both risk factors and coronary artery disease in patients referred for coronary angiography Am Heart J 2004;148:137-143.[Medline]
  15. Weisenberg D, Sahar Y, Sahar G, et al. Atherosclerosis of the aorta is common in patients with severe aortic stenosis: an intraoperative transesophageal echocardiographic study J Thorac Cardiovasc Surg 2005;130:29-32.[Abstract/Free Full Text]
  16. Fazio GP, Redberg RF, Winslow T, Schiller NB. Transesophageal echocardiographically detected atherosclerotic aortic plaque is a marker for coronary artery disease J Am Coll Cardiol 1993;21:144-150.[Medline]
  17. Demopoulos LA, Tunick PA, Bernstein NE, Perez JL, Kronzon I. Protruding atheromas of the aortic arch in symptomatic patients with carotid artery disease Am Heart J 1995;129:40-44.[Medline]
  18. Kitaoka H, Okawa M, Kuwabara M, et al. Comparison of thoracic aortic atherosclerotic plaque by echocardiography in patients with stenotic tricuspid versus bicuspid aortic valves Am J Cardiol 2003;91:895-896.[Medline]
  19. Fayad ZA, Nahar T, Fallon JT, et al. In vivo magnetic resonance evaluation of atherosclerotic plaques in the human thoracic aorta: a comparison with transesophageal echocardiography Circulation 2000;101:2503-2509.[Abstract/Free Full Text]
  20. Katz ES, Tunick PA, Rusinek H, et al. Protruding aortic atheromas predict stroke in elderly patients undergoing cardiopulmonary bypass: a review of our experience with intraoperative transesophageal echocardiography J Am Coll Cardiol 1992;20:70-77.[Medline]
  21. Stern A, Tunick PA, Culliford AT, et al. Protruding aortic arch atheromas: risk of stroke during heart surgery with and without aortic arch endarterectomy Am Heart J 1999;138:746-752.[Medline]
  22. Kronzon I, Tunick PA. Aortic atherosclerotic disease and stroke Circulation 2006;114:63-75.[Free Full Text]
  23. Wareing TH, Davila-Roman VG, Barzilai B, Murphy SF, Kouchoukos NT. Management of the severely atherosclerotic ascending aorta during cardiac operations: a strategy for detection and treatment J Thorac Cardiovasc Surg 1992;103:453-462.[Abstract]
  24. Gold JP, Torres KE, Maldarelli W, Zhuravlev I, Condit D, Wasnick J. Improving outcomes in coronary surgery: the impact of echo-directed aortic cannulation and perioperative hemodynamic management in 500 patients Ann Thorac Surg 2004;78:1579-1585.[Abstract/Free Full Text]
  25. Trehan N, Mishra M, Kasliwal RR, Mishra A. Surgical strategies in patients at high risk for stroke undergoing coronary artery bypass grafting. Ann Thorac Surg 200;70:1037–45.
  26. Sabik JF, Nemeh H, Lytle BW, et al. Cannulation of the axillary artery with a side graft reduces morbidity Ann Thorac Surg 2004;77:1315-1320.[Abstract/Free Full Text]
  27. Byrne JG, Aranki SF, Cohn LH. Aortic valve operations under deep hypothermic circulatory arrest for the porcelain aorta: "no-touch" technique Ann Thorac Surg 1998;65:1313-1315.[Abstract/Free Full Text]
  28. Zingone B, Gatti G, Rauber E, Pappalardo A, Benussi B, Dreas L. Surgical management of the atherosclerotic ascending aorta: is endoaortic balloon occlusion safe? Ann Thorac Surg 2006;82:1709-1714.[Abstract/Free Full Text]
  29. Gillinov AM, Lytle BW, Hoang V, et al. The atherosclerotic aorta at aortic valve replacement: surgical strategies and results J Thorac Cardiovasc Surg 2000;120:957-963.[Abstract/Free Full Text]
  30. Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies Circulation 2005;111:3316-3326.[Free Full Text]
  31. Vaughan CJ, Gotto AM, Basson CT. The evolving role of statins in the management of atherosclerosis J Am Coll Cardiol 2000;35:1-10.[Medline]
  32. Cowell SJ, Newby DE, Prescott RJ, et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis N Engl J Med 2005;352:2389-2397.[Medline]
  33. Moura LM, Ramos SF, Zamorano JL, et al. Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis J Am Coll Cardiol 2007;49:554-561.[Medline]
  34. Griffin BP. Statins in aortic stenosis: new data from a prospective clinical trial J Am Coll Cardiol 2007;49:562-564.[Medline]

Related Article

Invited commentary
Alfred Culliford
Ann. Thorac. Surg. 2008 85: 119. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
B. Zingone, G. Gatti, A. Spina, E. Rauber, L. Dreas, G. Forti, and A. Pappalardo
Current Role and Outcomes of Ascending Aortic Replacement for Severe Nonaneurysmal Aortic Atherosclerosis
Ann. Thorac. Surg., February 1, 2010; 89(2): 429 - 434.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. Culliford
Invited commentary
Ann. Thorac. Surg., January 1, 2008; 85(1): 119 - 119.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Alfredo Trento
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goland, S.
Right arrow Articles by Siegel, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goland, S.
Right arrow Articles by Siegel, R. J.
Related Collections
Right arrow Coronary disease
Right arrow Valve disease
Right arrowRelated Article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS